{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:23:53Z","timestamp":1769833433734,"version":"3.49.0"},"reference-count":93,"publisher":"Tech Science Press","issue":"3","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":425,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.32604\/or.2022.027511","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T03:23:06Z","timestamp":1673580186000},"page":"117-128","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Treatment options in stage I seminoma"],"prefix":"10.32604","volume":"30","author":[{"given":"UROS","family":"BUMBASIREVIC","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARKO","family":"ZIVKOVIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MILOS","family":"PETROVIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VESNA","family":"CORIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NIKOLA","family":"LISICIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NEBOJSA","family":"BOJANIC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e12390","DOI":"10.1097\/MD.0000000000012390","article-title":"Recent global trends in testicular cancer incidence and mortality","volume":"97","author":"Park","year":"2018","journal-title":"Medicine"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.eururo.2019.07.002","article-title":"International trends in the incidence of testicular cancer: Lessons from 35 years and 41 countries","volume":"76","author":"Gurney","year":"2019","journal-title":"European Urology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/S0140-6736(15)00991-5","article-title":"Testicular germ cell tumours","volume":"387","author":"Rajpert-De Meyts","year":"2016","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","article-title":"ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org; EURACAN. Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oldenburg","year":"2022","journal-title":"Annals of Oncology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrurol.2016.164","article-title":"Management of stage I testicular germ cell tumours","volume":"13","author":"Chovanec","year":"2016","journal-title":"Nature Reviews Urology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2014","journal-title":"Cancer Medicine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1586\/14737140.8.7.1081","article-title":"Exploration of treatment options for the management of stage I testicular seminoma","volume":"8","author":"Bernal","year":"2008","journal-title":"Expert Review of Anticancer Therapy"},{"key":"ref8","year":"2022","journal-title":"Edn. presented at the EAU Annual Congress Amsterdam 2022"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/annonc\/mdu514","article-title":"Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer","volume":"26","author":"Oldenburg","year":"2015","journal-title":"Annals of Oncology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Orchidectomy alone for stage I seminoma of the testis","volume":"65","author":"Duchesne","year":"1990","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/0959-8049(93)90446-M","article-title":"Surveillance following orchidectomy for stage I seminoma of the testis","volume":"29","author":"von der Maase","year":"1993","journal-title":"European Journal of Cancer"},{"key":"ref12","first-page":"1637","article-title":"Surveillance in stage I testicular seminoma-risk of late relapse","volume":"9","author":"Chung","year":"2002","journal-title":"The Canadian Journal of Urology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/annonc\/mdg241","article-title":"Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma","volume":"14","author":"Aparicio","year":"2003","journal-title":"Annals of Oncology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1034\/j.1600-0463.2003.11101111.x","article-title":"Surveillance in stage I testicular cancer","volume":"111","author":"Daugaard","year":"2003","journal-title":"APMIS"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ijrobp.2004.06.209","article-title":"Long-term outcome of postorchiectomy surveillance for stage I testicular seminoma","volume":"61","author":"Choo","year":"2005","journal-title":"International Journal of Radiation, Oncology, Biology, Physics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/bju.12330","article-title":"Treatment burden in stage I seminoma: A comparison of surveillance and adjuvant radiation therapy","volume":"112","author":"Leung","year":"2013","journal-title":"BJU International"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00345-009-0409-x","article-title":"Current treatment options for clinical stage I seminoma","volume":"27","author":"Stephenson","year":"2009","journal-title":"World Journal of Urology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1586\/era.10.82","article-title":"Management options for stage I seminoma","volume":"10","author":"Aparicio","year":"2010","journal-title":"Expert Review of Anticancer Therapy"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.critrevonc.2007.04.014","article-title":"A comprehensive systematic review of testicular germ cell tumor surveillance","volume":"64","author":"Groll","year":"2007","journal-title":"Critical Review of Oncology\/Hematology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.eururo.2016.07.013","article-title":"Conditional risk of relapse in surveillance for clinical stage I testicular cancer","volume":"71","author":"Nayan","year":"2017","journal-title":"European Urology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/COC.0b013e318254950a","article-title":"Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: A surveillance, epidemiology, and end results (SEER) analysis","volume":"36","author":"Jones","year":"2013","journal-title":"American Journal of Clinical Oncology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2015.09.028","article-title":"Surveillance and radiation therapy for stage I seminoma--have we learned from the evidence?","volume":"94","author":"Glaser","year":"2015","journal-title":"International Journal of Radiation, Oncology, Biology, Physics"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clgc.2019.04.015","article-title":"Contemporary assessment of survival rates in stage I testicular seminoma: A population-based comparison between surveillance and active treatment after orchiectomy","volume":"17","author":"Mistretta","year":"2019","journal-title":"Clinical Genitourinary Cancer"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO consensus conference on testicular germ cell cancer: Diagnosis, treatment and follow-up","volume":"29","author":"Honecker","year":"2018","journal-title":"Annals of Oncology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.crad.2008.10.011","article-title":"Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours","volume":"64","author":"Sohaib","year":"2009","journal-title":"Clinical Radiology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/0284186X.2020.1725243","article-title":"Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: A prospective trial","volume":"59","author":"Laukka","year":"2020","journal-title":"Acta Oncologica"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1200\/JCO.21.01199","article-title":"TRISST trial management group and investigators. Imaging modality and frequency in surveillance of stage I seminoma testicular cancer: Results from a randomized, phase III, noninferiority trial (TRISST)","volume":"40","author":"Joffe","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1200\/JCO.2008.19.9406","article-title":"Quality of surveillance for stage I testis cancer in the community","volume":"27","author":"Yu","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urolonc.2005.05.010","article-title":"Treatment of stage I seminoma: A 15-year review","volume":"3","author":"Alomary","year":"2005","journal-title":"Urologic Oncology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/jjco\/hyu001","article-title":"Risk factors for loss to follow-up during active surveillance of patients with stage I seminoma","volume":"44","author":"Endo","year":"2014","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"ref32","first-page":"397","article-title":"Active surveillance for testicular tumors: Adherence and safety","volume":"74","author":"Rico","year":"2021","journal-title":"Archivos Espanoles de Urologia"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0022-5347(01)66452-8","article-title":"Psychosocial aspects in long-term survivors of testicular cancer","volume":"155","author":"Arai","year":"1996","journal-title":"Journal of Urology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1200\/JCO.1996.14.11.2933","volume":"14","author":"Sharda","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/RRU.S74125","article-title":"Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma","volume":"8","author":"Cox","year":"2015","journal-title":"Research and Reports in Urology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/bjc.2014.552","article-title":"Increased stomach cancer risk following radiotherapy for testicular cancer","volume":"112","author":"Hauptmann","year":"2015","journal-title":"British Journal of Cancer"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1200\/JCO.2004.05.205","article-title":"Mortality after cure of testicular seminoma","volume":"22","author":"Zagars","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","article-title":"Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer","volume":"25","author":"van den Belt-Dusebout","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/bjc.2013.551","article-title":"Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma","volume":"110","author":"Horwich","year":"2014","journal-title":"British Journal of Cancer"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.urolonc.2017.06.051","article-title":"Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival","volume":"35","author":"Patel","year":"2017","journal-title":"Urologic Oncology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","article-title":"Treatment-associated leukemia following testicular cancer","volume":"92","author":"Travis","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: A 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1200\/JCO.2003.04.173","article-title":"Cardiovascular disease as a long-term complication of treatment for testicular cancer","volume":"21","author":"Huddart","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bju.14455","article-title":"Fertility managment in testicular cancer: The need to establish a standardized and evidence-based patient-centric pathway","volume":"123","author":"Moody","year":"2019","journal-title":"BJU International"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/humrep\/del167","article-title":"Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients","volume":"21","author":"Gandini","year":"2006","journal-title":"Human Reproduction"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/annonc\/mdz017","article-title":"Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment","volume":"30","author":"Weibring","year":"2019","journal-title":"Annals of Oncology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.urolonc.2013.10.002","article-title":"Late gastrointestinal morbidity in patients with stage I\u2013II testicular seminoma treated with radiotherapy","volume":"32","author":"Hallemeier","year":"2014","journal-title":"Urologic Oncology"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","article-title":"Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial. Medical research council testicular tumor working group","volume":"17","author":"Foss\u00e5","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","article-title":"Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: A report on medical research council trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)","volume":"23","author":"Jones","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0167-8140(99)00023-7","article-title":"Seminoma of the testis: Is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes?","volume":"50","author":"Bieri","year":"1999","journal-title":"Radiotherapy and Oncology"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"240.e1","DOI":"10.1016\/j.urolonc.2020.08.025","article-title":"Contemporary trends in management of stage 1 seminoma","volume":"39","author":"Frankel","year":"2021","journal-title":"Urologic Oncology"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0749-2081(89)90083-1","article-title":"Carboplatin: A clinical review","volume":"5","author":"Yarbro","year":"1989","journal-title":"Seminars in Oncology Nursing"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0305-7372(85)90014-3","article-title":"Preclinical antitumor and toxicologic profile of carboplatin","volume":"12","author":"Rose","year":"1985","journal-title":"Cancer Treatment Reviews"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/jnci\/80.2.131","article-title":"Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia","volume":"80","author":"Lee","year":"1988","journal-title":"Journal of the National Cancer Institute"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0360-3016(94)90219-4","article-title":"Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?","volume":"29","author":"Oliver","year":"1994","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","article-title":"Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomised trial","volume":"366","author":"Oliver","year":"2005","journal-title":"Lancet"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","article-title":"Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982 study (ISRCTN27163214)","volume":"29","author":"Oliver","year":"2011","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/annonc\/mdv254","article-title":"Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: Results from a 17-year UK experience","volume":"26","author":"Chau","year":"2015","journal-title":"Annals of Oncology"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/j.clgc.2015.12.009","article-title":"Adjuvant carboplatin treatment in 115 patients with stage I seminoma: Retrospective multicenter survey","volume":"14","author":"Diminutto","year":"2016","journal-title":"Clinical Genitourinary Cancer"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1200\/JCO.2016.69.0958","article-title":"Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma","volume":"35","author":"Fischer","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"ref62","first-page":"5432","article-title":"Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function","volume":"44","author":"Egorin","year":"1984","journal-title":"Cancer Research"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: Prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"Journal of Clinical Oncology"},{"key":"ref64","first-page":"613","article-title":"Glomerular filtration rate: Which method should we measure in daily clinical practice?","volume":"104","author":"Yildiz","year":"2013","journal-title":"Minerva Medica"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/annonc\/mdu129","article-title":"Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort","volume":"25","author":"Cathomas","year":"2014","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.urolonc.2005.03.004","article-title":"Quality of life in survivors of testicular cancer","volume":"23","author":"Dahl","year":"2005","journal-title":"Urologic Oncology"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/annonc\/mdm540","article-title":"The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis","volume":"19","author":"Powles","year":"2008","journal-title":"Annals of Oncology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2010.29.5055","article-title":"Carboplatin in clinical stage I seminoma: Too much and too little at the same time","volume":"29","author":"Bosl","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/sj.bjc.6602020","article-title":"Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: A pooled analysis of two randomised trials","volume":"91","author":"Bokemeyer","year":"2004","journal-title":"British Journal of Cancer"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/annonc\/mdj039","article-title":"Single agent carboplatin for CS IIA\/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG)","volume":"17","author":"Krege","year":"2006","journal-title":"Annals of Oncology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00432-016-2162-z","article-title":"Testicular seminoma clinical stage 1: Treatment outcome on a routine care level","volume":"142","author":"Dieckmann","year":"2016","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/annonc\/mdw164","article-title":"Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)","volume":"27","author":"Tandstad","year":"2016","journal-title":"Annals of Oncology"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"8717","DOI":"10.1200\/JCO.2005.01.9810","article-title":"Risk-adapted management for patients with clinical stage I seminoma: The Second Spanish Germ Cell Cancer Cooperative Group study","volume":"23","author":"Aparicio","year":"2005","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1200\/JCO.2011.36.0503","article-title":"Risk-adapted treatment in clinical stage I testicular seminoma: The third Spanish germ cell cancer group study","volume":"29","author":"Aparicio","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000487438","article-title":"A risk-adapted approach to patients with stage I seminoma according to the status of rete testis: The fourth Spanish germ cell cancer group study","volume":"95","author":"Aparicio","year":"2018","journal-title":"Oncology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/tau.2019.09.32","article-title":"Contemporary management of early stage testicular seminoma","volume":"9","author":"Aydin","year":"2020","journal-title":"Translational Andrology and Urology"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/bjc.1992.164","article-title":"Surveillance following orchidectomy for stage I testicular seminoma","volume":"65","author":"Horwich","year":"1992","journal-title":"British Journal of Cancer"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0022-5347(01)64839-0","article-title":"Prognostic factors for relapse in stage I testicular seminoma treated with surveillance","volume":"157","author":"Warde","year":"1997","journal-title":"The Journal of Urology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Medicine"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.eururo.2017.09.025","article-title":"Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: A systematic review by the testicular cancer guidelines panel","volume":"73","author":"Boormans","year":"2018","journal-title":"European Urology"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.urolonc.2017.06.047","article-title":"Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance\u2212A systematic review","volume":"36","author":"Zengerling","year":"2018","journal-title":"Urologic Oncology"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/his.12657","article-title":"Handling and reporting of orchidectomy specimens with testicular cancer: Areas of consensus and variation among 25 experts and 225 European pathologists","volume":"67","author":"Berney","year":"2015","journal-title":"Histopathology"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/ijms22031380","article-title":"miRNAs and biomarkers in testicular germ cell tumours: An update","volume":"22","author":"de Martino","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.eururo.2021.06.006","article-title":"Circulating microRNAs, the next-generation serum biomarkers in testicular germ cell tumours: A systematic review","volume":"80","author":"Le\u00e3o","year":"2021","journal-title":"European Urology"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00330-014-3507-0","article-title":"Radiation exposure from diagnostic imaging in young patients with testicular cancer","volume":"25","author":"Sullivan","year":"2015","journal-title":"European Radiology"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.urology.2007.07.016","article-title":"Two cycles of etoposide\/cisplatin cured all patients with stage I testicular seminoma: Risk-adapted protocol of the hellenic cooperative oncology group","volume":"70","author":"Bamias","year":"2007","journal-title":"Urology"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000502658","article-title":"May high levels of systemic immune-inflammation index and hematologic inflammation markers suggest a further stage in testicular tumours?","volume":"103","author":"Imamoglu","year":"2019","journal-title":"Urologia Internationalis"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/jpm12050833","article-title":"Interplay between comprehensive inflammation indices and redox biomarkers in testicular germ-cell tumors","volume":"12","author":"Bumbasirevic","year":"2022","journal-title":"Journal of Personalized Medicine"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/andr.12814","article-title":"p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome","volume":"8","author":"Lobo","year":"2020","journal-title":"Andrology"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euo.2020.11.004","article-title":"Utility of serum miR-371a-3p in predicting relapse on surveillance in patients with clinical stage I testicular germ cell cancer","volume":"4","author":"Lobo","year":"2021","journal-title":"European Urology Oncolology"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/bju.14372","article-title":"Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours","volume":"122","author":"Lewin","year":"2018","journal-title":"BJU International"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.3390\/cancers13215573","article-title":"Screening for the key proteins associated with rete testis invasion in clinical stage I seminoma via label-free quantitative mass spectrometry","volume":"13","author":"Borsz\u00e9kov\u00e1 Pulzov\u00e1","year":"2021","journal-title":"Cancers"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2022\/TSP_OR-30-3\/OncolRes-30-03-27511\/OncolRes-30-27511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:59:37Z","timestamp":1733522377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v30n3\/51288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2022.027511","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"2022-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-01-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-12","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}